Imugene Commences Patient Dosing in Phase 1 Bile Tract Cancer Trial; Shares Up 8%
Imugene Commences Patient Dosing in Phase 1 Bile Tract Cancer Trial; Shares Up 8%
Imugene公司已开始第1期胆管癌临床试验的患者用药；股价上涨8％。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册